158 related articles for article (PubMed ID: 35312818)
21. [Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].
Yang C; Liu F; Han M; Li B; Shen Q; Xu P; Yang Q
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jun; 32(6):711-715. PubMed ID: 32684218
[TBL] [Abstract][Full Text] [Related]
22. Cardiac troponin T and NT-proBNP for detecting myocardial ischemia in suspected chronic coronary syndrome.
Myhre PL; Røsjø H; Sarvari SI; Ukkonen H; Rademakers F; Engvall JE; Hagve TA; Nagel E; Sicari R; Zamorano JL; Monaghan M; D'hooge J; Edvardsen T; Omland T
Int J Cardiol; 2022 Aug; 361():14-17. PubMed ID: 35577165
[TBL] [Abstract][Full Text] [Related]
23. Assessing the cardiotoxicity of Epirubicin-based chemotherapy in patients with breast cancer using high-sensitivity cardiac troponin T, N-terminal pro b-type natriuretic peptide and soluble suppression of tumorigenicity-2.
Isemede DA; Sharma A; Bailey J
Ann Clin Biochem; 2022 Nov; 59(6):410-419. PubMed ID: 36154484
[TBL] [Abstract][Full Text] [Related]
24. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
[TBL] [Abstract][Full Text] [Related]
25. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
[TBL] [Abstract][Full Text] [Related]
26. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide predict mortality in stable coronary artery disease: results from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
Giannitsis E; Spanuth E; Horsch A; Kleber ME; Koch W; Grammer TB; Koenig W; März W
Clin Chem Lab Med; 2013 Oct; 51(10):2019-28. PubMed ID: 24072576
[TBL] [Abstract][Full Text] [Related]
27. Relationship between high-sensitivity cardiac troponin T and the prognosis of elderly inpatients with non-acute coronary syndromes.
Wu W; Li DX; Wang Q; Xu Y; Cui YJ
Clin Interv Aging; 2018; 13():1091-1098. PubMed ID: 29922047
[TBL] [Abstract][Full Text] [Related]
28. High-sensitivity troponin T improves the prognostic value of N-terminal pro-B-type natriuretic peptide in patients with stable coronary artery disease: results from the LURIC Study.
Ivandic BT; Spanuth E; Kleber M; Grammer TB; März W
Clin Chem Lab Med; 2011 Jun; 49(6):1053-8. PubMed ID: 21574877
[TBL] [Abstract][Full Text] [Related]
29. Prognostic Implications of N-Terminal Pro-B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T in EMPEROR-Preserved.
Januzzi JL; Butler J; Zannad F; Filippatos G; Ferreira JP; Pocock SJ; Sattar N; Verma S; Vedin O; Iwata T; Brueckmann M; Packer M; Anker SD;
JACC Heart Fail; 2022 Jul; 10(7):512-524. PubMed ID: 35670067
[TBL] [Abstract][Full Text] [Related]
30. Interrelationship in the prognostic efficacy of regional coronary flow reserve, fractional flow reserve, high-sensitivity cardiac troponin-I and NT-proBNP in patients with stable coronary artery disease.
Hamaya R; Yonetsu T; Kanaji Y; Usui E; Hoshino M; Hada M; Kanno Y; Murai T; Lee T; Kakuta T
Heart Vessels; 2019 Mar; 34(3):410-418. PubMed ID: 30229410
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of mean platelet volume as a biomarker for long-term clinical outcomes after percutaneous coronary intervention in Korean cohort: a comparable and additive predictive value to high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide.
Ki YJ; Park S; Ha SI; Choi DH; Song H
Platelets; 2014; 25(6):427-32. PubMed ID: 24102424
[TBL] [Abstract][Full Text] [Related]
32. Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes.
Gianatti EJ; Hoermann R; Lam Q; Dupuis P; Zajac JD; Grossmann M
Clin Endocrinol (Oxf); 2016 Jan; 84(1):55-62. PubMed ID: 26120052
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers and Coronary Lesions Predict Outcomes after Revascularization in Non-ST-Elevation Acute Coronary Syndrome.
Lindholm D; James SK; Bertilsson M; Becker RC; Cannon CP; Giannitsis E; Harrington RA; Himmelmann A; Kontny F; Siegbahn A; Steg PG; Storey RF; Velders MA; Weaver WD; Wallentin L;
Clin Chem; 2017 Feb; 63(2):573-584. PubMed ID: 27932413
[TBL] [Abstract][Full Text] [Related]
34. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
[TBL] [Abstract][Full Text] [Related]
36. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure.
Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM
Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019
[TBL] [Abstract][Full Text] [Related]
37. Association of GDF-15, hs-cTnT and NT-proBNP with coronary artery disease in patients undergoing elective angiography.
Souaid T; Hijazi Z; Barakett V; Sarkis A; Kadri Z; Batra G; Lindbäck J; Abdelmassih T; Azar RR
Future Cardiol; 2022 Aug; 18(8):635-646. PubMed ID: 35678322
[TBL] [Abstract][Full Text] [Related]
38. Epicardial fat thickness in stable coronary artery disease: its relationship with high-sensitive cardiac troponin T and N-terminal pro-brain natriuretic peptide.
Börekçi A; Gür M; Özaltun B; Baykan AO; Harbalioğlu H; Seker T; Sen Ö; Acele A; Gözükara MY; Kuloğlu O; Koç M; Çayli M
Coron Artery Dis; 2014 Dec; 25(8):685-90. PubMed ID: 25004239
[TBL] [Abstract][Full Text] [Related]
39. Risk stratification in stable coronary artery disease is possible at cardiac troponin levels below conventional detection and is improved by use of N-terminal pro-B-type natriuretic peptide.
Lyngbæk S; Winkel P; Gøtze JP; Kastrup J; Gluud C; Kolmos HJ; Kjøller E; Jensen GB; Hansen JF; Hildebrandt P; Hilden J;
Eur J Prev Cardiol; 2014 Oct; 21(10):1275-84. PubMed ID: 23723326
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of all-cause mortality and cardiovascular safety in patients receiving chimeric antigen receptor T cell therapy: a prospective cohort study.
Korell F; Entenmann L; Romann S; Giannitsis E; Schmitt A; Müller-Tidow C; Frey N; Dreger P; Schmitt M; Lehmann LH
EClinicalMedicine; 2024 Mar; 69():102504. PubMed ID: 38544797
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]